Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 759-772

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 161-174

Bentham Science Publishers

Access to resources Recommend Favorite

Fatty Acid Amide Hydrolase Inhibitors - Progress and Potential

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 545-558

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of steroids for CNS disorders

By Hamilton Niall M  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 10, 2001-10 ,pp. : 1523-1531

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors

By Deng Hongfeng  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 961-993

Informa Healthcare

Access to resources Recommend Favorite